anonymous
Guest
anonymous
Guest
Gilmore now Strom. Are these related reasons?
Who are losing share to? Jeaveau and RHA? I am really worried about the filler launch from Evolus.It has been on the cards for a while with the US performance as terrible as it is. Glen is the guy who can sort things out. Maybe now we’ll get some proper investment when Jeff is confident it won’t get spent on waste of time consumer pushes meanwhile the share tanks.
Carrie on my wayword Strom.Gilmore now Strom. Are these related reasons?
Haha! Yes, he’s going to fix and sort this out. He’ll be the one to differentiate Botox and Juvederm from all the other products to show the market why it’s more expensive. HCPs will agree and will buy the most expensive products. The differentiation Glen produces will show its works significantly faster, last significantly longer and in a very accurate way which is the reason why we will charge more.It has been on the cards for a while with the US performance as terrible as it is. Glen is the guy who can sort things out. Maybe now we’ll get some proper investment when Jeff is confident it won’t get spent on waste of time consumer pushes meanwhile the share tanks.
Well said. Crowded and tough market now with more to come. Going to be very tough to grow and maintain share no matter who is in charge.Haha! Yes, he’s going to fix and sort this out. He’ll be the one to differentiate Botox and Juvederm from all the other products to show the market why it’s more expensive. HCPs will agree and will buy the most expensive products. The differentiation Glen produces will show its works significantly faster, last significantly longer and in a very accurate way which is the reason why we will charge more.
GTFOOH. He’s another person trying to steer a boat through a plethora of products that also work. New name, same result.
Costco’s tissue works just as well compared to Kleenex, and much cheaper.
But why is it a crowded and tough market. We were there first. We have been investing in R&D and BD before anyone else. Shouldn’t we have new and differentiated products? Why does evolus have a new filler? Why don’t we? Who is making the decisions that got us here? Really.Well said. Crowded and tough market now with more to come. Going to be very tough to grow and maintain share no matter who is in charge.
I don’t think growth is there like in the past plus more competition makes it hard to meet expectations. Just my 2 cents.It's not like anyone else in aesthetics has launched a differentiated product either. Evolus filler is nothing new. Not holding my breath that any "next generation" product will shake up this industry. We all saw what happened with Revance.
AbbVie is slowly but surely getting rid of AGN brass so they can fill w their own. All the top leaders have ALL been pushed out. Name one person who is left.I’m long gone from agn but this caught my attention. What happened to her? She’s gone from agn/abbvie? I am selfishly curious about this one….
Jag D is still there.AbbVie is slowly but surely getting rid of AGN brass so they can fill w their own. All the top leaders have ALL been pushed out. Name one person who is left.
Jag D is still there.
That’s true, who is still left from AllerganAesthetics?Jag D is still there.
He was useless. Spent money like crazy and no return.Gilmore now Strom. Are these related reasons?
Glen is also from agn, but like Jag has been abbviefied. There are lots of aa left in international who are in for a rude wakening as aa will become a business unit under abbvie gms. Wonder if they will keep the money losing international marketing org. All aa does is travel business class around the globe. Sweet job.That’s true, who is still left from AllerganAesthetics?
More layoffs can be expected in international. Too many senior leaders not delivering results.Glen is also from agn, but like Jag has been abbviefied. There are lots of aa left in international who are in for a rude wakening as aa will become a business unit under abbvie gms. Wonder if they will keep the money losing international marketing org. All aa does is travel business class around the globe. Sweet job.
Juveau, Daxxify, RHA and soon Evolysse. Followed by Croma fillers, Letybo….The Allergan high price value proposition and commercial arrogance is no longer the way to win in the increasingly crowded aesthetic space.Who are losing share to? Jeaveau and RHA? I am really worried about the filler launch from Evolus.
This is 100% accurate. They all work in some degree, AGN’s price doesn’t support the product. It doesn’t work twice as long yet it’s two times more expensive. Greed and ego on full display.Juveau, Daxxify, RHA and soon Evolysse. Followed by Croma fillers, Letybo….The Allergan high price value proposition and commercial arrogance is no longer the way to win in the increasingly crowded aesthetic space.
Also fully agree. Allergan needs to reinvent itself quickly or the share erosion will continue.This is 100% accurate. They all work in some degree, AGN’s price doesn’t support the product. It doesn’t work twice as long yet it’s two times more expensive. Greed and ego on full display.